Cargando…
Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis
Behçet’s syndrome (BS) is a rare systemic vasculitis characterized by different clinical manifestations. As no specific laboratory tests exist, the diagnosis relies on clinical criteria, and the differential diagnosis with other inflammatory diseases can be challenging. Indeed, in a relatively small...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218865/ https://www.ncbi.nlm.nih.gov/pubmed/37240162 http://dx.doi.org/10.3390/ijms24108817 |
_version_ | 1785048875195695104 |
---|---|
author | Bettiol, Alessandra Fagni, Filippo Mattioli, Irene Bagni, Giacomo Vitiello, Gianfranco Grassi, Alessia Della Bella, Chiara Benagiano, Marisa Troilo, Arianna Holownia, Katarzyna Stella Simon, David Argento, Flavia Rita Sota, Jurgen Fabiani, Claudia Becatti, Matteo Fiorillo, Claudia Schett, Georg Lopalco, Giuseppe Cantarini, Luca Prisco, Domenico Silvestri, Elena Emmi, Giacomo D’Elios, Mario Milco |
author_facet | Bettiol, Alessandra Fagni, Filippo Mattioli, Irene Bagni, Giacomo Vitiello, Gianfranco Grassi, Alessia Della Bella, Chiara Benagiano, Marisa Troilo, Arianna Holownia, Katarzyna Stella Simon, David Argento, Flavia Rita Sota, Jurgen Fabiani, Claudia Becatti, Matteo Fiorillo, Claudia Schett, Georg Lopalco, Giuseppe Cantarini, Luca Prisco, Domenico Silvestri, Elena Emmi, Giacomo D’Elios, Mario Milco |
author_sort | Bettiol, Alessandra |
collection | PubMed |
description | Behçet’s syndrome (BS) is a rare systemic vasculitis characterized by different clinical manifestations. As no specific laboratory tests exist, the diagnosis relies on clinical criteria, and the differential diagnosis with other inflammatory diseases can be challenging. Indeed, in a relatively small proportion of patients, BS symptoms include only mucocutaneous, articular, gastrointestinal, and non-typical ocular manifestations, which are frequently found also in psoriatic arthritis (PsA). We investigate the ability of serum interleukin (IL)-36α—a pro-inflammatory cytokine involved in cutaneous and articular inflammatory diseases—to differentiate BS from PsA. A cross-sectional study was performed on 90 patients with BS, 80 with PsA and 80 healthy controls. Significantly lower IL-36α concentrations were found in patients with BS as compared to PsA, although in both groups IL-36α was significantly increased compared to healthy controls. An empirical cut-off of 420.6 pg/mL displayed a specificity of 0.93, with a sensitivity of 0.70 (AUC 0.82) in discriminating PsA from BS. This cut-off displayed a good diagnostic performance also in BS patients lacking highly specific BS manifestations. Our results indicate that IL-36α might be involved in the pathogenesis of both BS and PsA, and might be a candidate biomarker to support the differential diagnosis of BS. |
format | Online Article Text |
id | pubmed-10218865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102188652023-05-27 Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis Bettiol, Alessandra Fagni, Filippo Mattioli, Irene Bagni, Giacomo Vitiello, Gianfranco Grassi, Alessia Della Bella, Chiara Benagiano, Marisa Troilo, Arianna Holownia, Katarzyna Stella Simon, David Argento, Flavia Rita Sota, Jurgen Fabiani, Claudia Becatti, Matteo Fiorillo, Claudia Schett, Georg Lopalco, Giuseppe Cantarini, Luca Prisco, Domenico Silvestri, Elena Emmi, Giacomo D’Elios, Mario Milco Int J Mol Sci Article Behçet’s syndrome (BS) is a rare systemic vasculitis characterized by different clinical manifestations. As no specific laboratory tests exist, the diagnosis relies on clinical criteria, and the differential diagnosis with other inflammatory diseases can be challenging. Indeed, in a relatively small proportion of patients, BS symptoms include only mucocutaneous, articular, gastrointestinal, and non-typical ocular manifestations, which are frequently found also in psoriatic arthritis (PsA). We investigate the ability of serum interleukin (IL)-36α—a pro-inflammatory cytokine involved in cutaneous and articular inflammatory diseases—to differentiate BS from PsA. A cross-sectional study was performed on 90 patients with BS, 80 with PsA and 80 healthy controls. Significantly lower IL-36α concentrations were found in patients with BS as compared to PsA, although in both groups IL-36α was significantly increased compared to healthy controls. An empirical cut-off of 420.6 pg/mL displayed a specificity of 0.93, with a sensitivity of 0.70 (AUC 0.82) in discriminating PsA from BS. This cut-off displayed a good diagnostic performance also in BS patients lacking highly specific BS manifestations. Our results indicate that IL-36α might be involved in the pathogenesis of both BS and PsA, and might be a candidate biomarker to support the differential diagnosis of BS. MDPI 2023-05-16 /pmc/articles/PMC10218865/ /pubmed/37240162 http://dx.doi.org/10.3390/ijms24108817 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bettiol, Alessandra Fagni, Filippo Mattioli, Irene Bagni, Giacomo Vitiello, Gianfranco Grassi, Alessia Della Bella, Chiara Benagiano, Marisa Troilo, Arianna Holownia, Katarzyna Stella Simon, David Argento, Flavia Rita Sota, Jurgen Fabiani, Claudia Becatti, Matteo Fiorillo, Claudia Schett, Georg Lopalco, Giuseppe Cantarini, Luca Prisco, Domenico Silvestri, Elena Emmi, Giacomo D’Elios, Mario Milco Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis |
title | Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis |
title_full | Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis |
title_fullStr | Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis |
title_full_unstemmed | Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis |
title_short | Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis |
title_sort | serum interleukin-36 α as a candidate biomarker to distinguish behçet’s syndrome and psoriatic arthritis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218865/ https://www.ncbi.nlm.nih.gov/pubmed/37240162 http://dx.doi.org/10.3390/ijms24108817 |
work_keys_str_mv | AT bettiolalessandra seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT fagnifilippo seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT mattioliirene seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT bagnigiacomo seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT vitiellogianfranco seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT grassialessia seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT dellabellachiara seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT benagianomarisa seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT troiloarianna seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT holowniakatarzynastella seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT simondavid seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT argentoflaviarita seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT sotajurgen seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT fabianiclaudia seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT becattimatteo seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT fiorilloclaudia seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT schettgeorg seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT lopalcogiuseppe seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT cantariniluca seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT priscodomenico seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT silvestrielena seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT emmigiacomo seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis AT deliosmariomilco seruminterleukin36aasacandidatebiomarkertodistinguishbehcetssyndromeandpsoriaticarthritis |